| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 3 |
| 1 | ADALIMUMAB | 2 |
| 2 | ASPIRIN | 2 |
| 3 | ASPIRIN 325 MG | 2 |
| 4 | ASPIRIN 81 MG | 2 |
| 5 | ACALABRUTINIB | 1 |
| 6 | ACETAMINOPHEN | 1 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 8 | ALBUTEROL SULFATE | 1 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BORON | 1 | 0.0033 |
| 1 | PRASTERONE | 1 | 0.0004 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 3 | GOLD | 1 | 0.0002 |
| 4 | NORTRIPTYLINE HYDROCHLORIDE | 1 | 0.0002 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 6 | GEMFIBROZIL | 1 | 0.0001 |
| 7 | ACALABRUTINIB | 1 | 0.0001 |
| 8 | LIFITEGRAST | 1 | 0.0001 |
| 9 | AMITRIPTYLINE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 2 |
| 2 | Androgen [EPC] | 1 |
| 3 | Antirheumatic Agent [EPC] | 1 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 5 | Corticosteroid [EPC] | 1 |
| 6 | Estrogen [EPC] | 1 |
| 7 | Expectorant [EPC] | 1 |
| 8 | Factor Xa Inhibitor [EPC] | 1 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 1 | Androgen [EPC] | 1 | 0.0000 |
| 2 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 4 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Fluoroquinolone Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |